TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Faron Pharmaceuticals Oy
Closing information (x1000 NOK)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover | 10,477 | 4,971 | 8,198 |
Financial expenses | 3,280 | 2,973 | 1,321 |
Earnings before taxes | -83,767 | -58,750 | -12,170 |
Total assets | 157,075 | 141,674 | 34,465 |
Current assets | 104,293 | 105,799 | 2,190 |
Current liabilities | 39,707 | 21,001 | 15,038 |
Equity capital | 98,886 | 106,851 | -6,053 |
- share capital | 24,451 | 25,723 | 24,349 |
Employees (average) | 10 | 6 | 5 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency | 63.0% | 75.4% | -17.6% |
Turnover per employee | 1,048 | 828 | 1,640 |
Profit as a percentage of turnover | -799.5% | -1181.9% | -148.5% |
Return on assets (ROA) | -51.2% | -39.4% | -31.5% |
Current ratio | 262.7% | 503.8% | 14.6% |
Return on equity (ROE) | -84.7% | -55.0% | 201.1% |
Change turnover | 5,752 | -3,690 | |
Change turnover % | 122% | -43% | |
Chg. No. of employees | 4 | 1 | |
Chg. No. of employees % | 67% | 20% |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.